For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.

As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...

Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...

On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for ...

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

A U.S. judge ordered federal agencies to restore access to health-related webpages and datasets removed by the Trump ...

Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries ...

When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

Better decision-making and more efficient claim handling are two outcomes of the revolution taking place in workers’ ...

Ken Paxton's opinion puts Texas on a collision course with employer groups that say ERISA should shield the plans from the ...